| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |